Aerosol performance and long-term stability of surfactant-associated liposomal ciprofloxacin formulations with modified encapsulation and release properties

AAPS PharmSciTech

Volumn 15, Issue 5, 2014, Pages 1218-1227

  Cipolla, David ^a,b   Wu, Huiying ^b   Gonda, Igor ^b   Chan, Hak Kim ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ARADIGM CORPORATION   (United States)

Author keywords

ciprofloxacin; drug delivery; liposome; nebulized aerosol; surfactant

Indexed keywords

ACETIC ACID; CIPROFLOXACIN; LIPOSOME; POLYSORBATE 20; SURFACTANT; AEROSOL; ANTIINFECTIVE AGENT; DELAYED RELEASE FORMULATION;

AEROSOL; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG STORAGE; ELECTRON MICROSCOPY; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LIGHT SCATTERING; NEBULIZATION; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; TRANSMISSION ELECTRON MICROSCOPY; CHEMISTRY; DELAYED RELEASE FORMULATION; MEDICINAL CHEMISTRY; PERSONALIZED MEDICINE;

AEROSOLS; ANTI-BACTERIAL AGENTS; CHEMISTRY, PHARMACEUTICAL; CIPROFLOXACIN; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; LIPOSOMES; PARTICLE SIZE; PRECISION MEDICINE; SURFACE-ACTIVE AGENTS;

EID: 84907879111     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-014-0155-2     Document Type: Article

References (25)

1. Drummond DC, Noble CO, Hayes ME, Park JW, Kirpotin DB. Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development. J Pharm Sci. 2008;97:4696-740.
2. Cipolla D, Gonda I, Chan HK. Liposomal formulations for inhalation. Ther Deliv. 2013;4(8):1047-72.
3. Cipolla D, Redelmeier T, Eastman S, Bruinenberg P, Gonda I. Liposomes, niosomes and proniosomes - a critical update of their (commercial) development as inhaled products. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, Young PM, editors. Respiratory drug delivery Europe 2011. River Grove: Davis Healthcare Int'l Publishing; 2011. p. 41-54.
4. Sharma A, Sharma US. Liposomes in drug delivery: progress and limitations. Int J Pharm. 1997;154(2):123-40.
5. Bonacucina G, Cespi M, Misici-Falzi M, Palmieri GF. Colloidal soft matter as drug delivery system. J Pharm Sci. 2009;98(1):1-42.
6. Cipolla D, Wu H, Eastman S, Redelmeier T, Gonda I, Chan H-K. Modifying the release properties of liposomes toward personalized medicine. J Pharm Sci. 2014;103(6):1851-62.
7. Taylor KM, Newton JM. Liposomes for controlled delivery of drugs to the lung. Thorax. 1992;47(4):257-9.
8. Schreier H, Gonzalez-Rothi RJ, Stecenko AA. Pulmonary delivery of liposomes. J Control Rel. 1993;47(4):257-9.
9. Monforte V, Lopez-Sanchez A, Zurbano F, Ussetti P, Sole A, Casals C, et al. Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant. J Heart Lung Transplant. 2013;32(3):313-9.
10. Cipolla D, Chan H-K. Inhaled antibiotics to treat lung infection. Pharm Patent Analyst. 2013;2(5):647-63.
11. Clancy JP, Dupont L, Konstan MW, et al. Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection. Thorax. 2013;68(9):818-25.
12. Bilton D, Pressler T, Fajac I, et al. Phase 3 efficacy and safety data from randomized, multicenter study of liposomal amikacin for inhalation (ARIKACE) Compared with TOBI in cystic fibrosis patients with chronic infection due to Pseudomonas Aeruginosa. Pediatr Pulmonol. 2013;48(S36):207-453.
13. Serisier DJ, Bilton D, De Soyza A, et al. Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial. Thorax. 2013;68:812-7.
14. Elhissi AM, Giebultowicz J, Stec AA, Wroczynski P, Ahmed W, Alhnan MA, et al. Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients. Int J Pharm. 2012;436(1-2):519-26.
15. Ong HX, Traini D, Cipolla D, Gonda I, Bebawy M, Agus H, et al. Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia. Pharm Res. 2012;29(12):3335-46.
16. Cipolla D, Wu H, Eastman S, Redelmeier T, Gonda I, Chan H-K. Development and characterization of an in vitro release assay for liposomal ciprofloxacin for inhalation. J Pharm Sci. 2013. doi: 10.1002/jps.23795.
17. Yim D, Blanchard JD, Mudumba S, Eastman S, Manda K, Redelmeier T, et al. The development of inhaled liposome-encapsulated ciprofloxacin to treat cystic fibrosis. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, editors. Respiratory drug delivery 2006. River Grove: Davis Healthcare Int'l Publishing; 2006. p. 425-8.
18. Webb MS, Boman NL, Wiseman DJ, Saxon D, Sutton K, Wong KF, et al. Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation. Antimicrob Agents Chemother. 1998;42(1):45-52.
19. Cipolla D, Dayton F, Fulzele S, Gabatan E, Mudumba S, Yim D, et al. Inhaled liposomal ciprofloxacin: in vitro properties and aerosol performance. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, Young PM, editors. Respiratory drug delivery 2010. River Grove: Davis Healthcare Int'l Publishing; 2010. p. 409-14.
20. Ruiz J, Goni FM, Alonso A. Surfactant-induced release of liposomal contents. A Surv of Methods and Results Biochim Biophys Acta. 1988;937(1):127-34.
21. Memoli A, Annesini MC, Petralito S. Surfactant-induced leakage from liposomes: a comparison among different lecithin vesicles. Int J Pharm. 1999;184(2):227-35.
22. Egle R, Bitterle E, Gruber F, Keller M. Characterization of a liposomal ciclosporin A formulation before and after lyophilization and nebulization. AAPS National Meeting, 2008. AM-08-00983.
23. Behr J, Zimmermann G, Baumgartner R, et al. Lung deposition of a liposomal cyclosporine A inhalation solution in patients after lung transplantation. J Aerosol Med Pulm Drug Deliv. 2009;22(2):121-30.
24. Cipolla D, Wu H, Chan J, Chan H-K, Gonda I. Liposomal ciprofloxacin for inhalation retains integrity following nebulization. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, Young PM, editors. Respiratory drug delivery Europe 2013. River Grove: Davis Healthcare Int'l Publishing; 2013. p. 237-42.
25. Elhissi AM, Faizi M, Naji WF, Gill HS, Taylor KM. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures. Int J Pharm. 2007;334(1-2):62-70.